Background Primary microcephaly (MCPH) is a genetically heterogeneous disorder showing an autosomal recessive mode of inheritance. Affected individuals present with head circumferences more than three SDs below the age-and sex-matched population mean, associated with mild to severe mental retardation. Five genes (MCPH1, CDK5RAP2, ASPM, CENPJ, STIL) and two genomic loci, MCPH2 and MCPH4, have been identified so far.
ABSTRACT Background Primary microcephaly (MCPH) is a genetically heterogeneous disorder showing an autosomal recessive mode of inheritance. Affected individuals present with head circumferences more than three SDs below the age-and sex-matched population mean, associated with mild to severe mental retardation.
Five genes (MCPH1, CDK5RAP2, ASPM, CENPJ, STIL) and two genomic loci, MCPH2 and MCPH4, have been identified so far.
Methods and results
In this study, we investigated all seven MCPH loci in patients with primary microcephaly from 112 Consanguineous Iranian families. In addition to a thorough clinical characterisation, karyotype analyses were performed for all patients. For Homozygosity mapping, microsatellite markers were selected for each locus and used for genotyping. Our investigation enabled us to detect homozygosity at MCPH1 (Microcephalin) in eight families, at MCPH5 (ASPM) in thirtheen families. Three families showed homozygosity at MCPH2 and five at MCPH6 (CENPJ), and two families were linked to MCPH7 (STIL). The remaining 81 families were not linked to any of the seven known loci. Subsequent sequencing revealed eight, 10 and one novel mutations in Microcephalin, ASPM and CENPJ, respectively. In some families, additional features such as short stature, seizures or congenital hearing loss were observed in the microcephalic patient, which widens the spectrum of clinical manifestations of mutations in known microcephaly genes. Conclusion Our results show that the molecular basis of microcephaly is heterogeneous; thus, the Iranian population may provide a unique source for the identification of further genes underlying this disorder.
Microcephaly is a disorder characterised by an occipito-frontal head circumference (OFC) of at least three standard deviations (SD) below the ageand sex-matched population average. 1 2 This disorder is aetiologically heterogeneous, with environmental and genetic causes. 3 Among the environmental causes are congenital infections, maternal alcohol overconsumption and drugs taken during pregnancy. The majority of microcephalic cases are caused by a variety of genetic mechanisms, including cytogenetic abnormalities, singlegene disorders, etc. Microcephaly is divided into primary microcephaly, which is present at birth, and secondary microcephaly, which develops postnatally. 4 The birth prevalence of primary microcephaly varies from 1.3 to 150 per 100 000 live births depending on the population and the defined SD threshold, 7 with w1 in 10 000 in consanguineous populations, less in non-consanguineous populations. 8 Primary nonsyndromal microcephaly has an birth prevalence of 1:30 000 to 1:250 000 live births. 3 7 Autosomal recessive primary microcephaly (MCPH, for microcephaly primary hereditary) is a rare, genetically heterogeneous disorder reported in about 100 families worldwide. 5 9 The initial defining clinical features of MCPH are OFC #3 SD at birth with mild to severe mental retardation and no further neurological findings except for mild seizures. However, recently, studies have shown that the phenotype spectrum of patients with MCPH gene mutations is wider than reported in previous publications. 7 9 13 15 19 There are at least seven MCPH loci, and the genes underlying six of these have been identified. These genes include Microcephalin at MCPH1, CDK5RAP2 at MCPH3, CEP152 at MCPH4 ASPM at MCPH5, CENPJ at MCPH6 and STIL/SIL at MCPH7 (table 1) . 3 5 7 8 20 35 So far, different mutations have been detected for these loci in different countries, e.g. Pakistani Turkey, Yemen, Saudi Arabia, Jordan, The Netherlands, Brazil, India and Canada. 3 7 20e25 35 Furthermore, it is evident that mutations in additional genes are associated with MCPH, as 18 out of 56 northern Pakistani families, 23 five of nine Indian families 3 and 10 of 33 Pakistani families 20 showed no evidence of linkage to the known loci. So far, no study has been carried out to evaluate the genetics of primary microcephaly in the Iranian population. Therefore, the aim of this study was to determine the molecular basis of primary microcephaly in the Iranian population.
MATERIALS AND METHODS Clinical examination
Our study included a total of 642 families with mentally retarded patients in which the majority of them had two or more affected individuals. All had been referred to the Genetics Research Center, Tehran, Iran as part of a large collaborative study on the identification of causes of familial mental retardation. These families belonged to various ethnicities from different provinces of Iran. Informed consent was obtained from all family members who participated in the study.
One hundred and twelve families out of 642 (17.5 %) showed primary microcephaly 2 and were divided into two groups: non-syndromic forms (92 families) and microcephaly associated with additional features (20 families). The number of affected individuals in the studied families ranged from one to eight. Consanguinity was observed in all families. Clinical histories indicated that microcephaly was present at birth in all of the affected individuals. On examination, head circumferences were 3 to 13 SD below the population age-and sex-related mean. All parents appeared to have normal intelligence and normal head circumferences.
DNA extraction and genotyping
DNA was extracted from peripheral blood samples following a standard protocol. 26 A panel of 70 (6 to 21 for the individual candidate regions) microsatellite markers (S1) was selected from the Genome Databases (http://www.gdb.org/ and http:// genome.ucsc.edu/). Since population-specific allele frequencies were not available for the Iranian population, we verified the percentage of allelic heterozygosity for these markers in 10 unrelated individuals from diverse ethnic groups: Persians (Tehran and Esfahan), Azaris, Gilaki and Mazandarani, Kurds, Arabs (Bandar-e Abbas and Ahvaz), Baluchi and Lurs. A minimum of two microsatellite markers per locus was genotyped in the parents, at least two affected children and one healthy sibling in each family. Conditions for PCR amplification of the microsatellite markers are available in the supplementary information (S2). Polyacrylamide gel electrophoresis and a standard silver stain protocol were used to visualise the results. When the haplotype at a given MCPH locus was found to be homozygous in all affected individuals of a family, mutation screening was initiated. If heterozygous markers or different homozygous haplotypes were found in the patients, the respective locus was excluded.
Karyotyping
To exclude the possibility of chromosomal aberrations as the cause of microcephaly in these families, high-resolution G-banding chromosomal analysis was performed for one affected individual in each family.
Sequencing of ASPM
The probands of the 13 families linked to the MCPH5 locus on chromosome 1q31, all 28 exons and exon/intron splice junctions of the ASPM gene (National Center for Biotechnology Information GenBank Accession Number AF509326), were sequenced using a set of 33 PCR primers (S3). After PCR amplification, the amplicons (S4) were sequenced using an ABI 3730 genetic analyser (Applied Biosystems, Foster city, California, USA.). Sequences were compared with the reference genomic and cDNA sequence (NM_018136).
Sequencing of microcephalin
We amplified the 14 exons and exon/intron splice junctions of the microcephalin gene (GenBank accession number AX087870) using a set of 16 primers (S5 and S6), designed with the Primer3 software, 23 and sequenced the amplicons as described above.
Sequencing of CENPJ
Using a set of 17 primer pairs (S7), designed with the Primer3 software, 27 the 17 exons and exon/intron splice junctions of the CENPJ gene (GenBank accession number BC024209) were amplified and sequenced as described above.
Sequencing of STIL
We amplified and sequenced the whole coding region, untranslated regions and exon/intron junctions of STIL (GenBank accession number NM_003035.2) using 23 primer pairs (S8).
RESULTS
In total, we studied 112 families with 315 MCPH patients including 158 men and 157 women (ratio 1:1) The number of affected individuals in each family ranged from one to eight (table 2) . The degree of microcephaly in the investigated patients ranged between 3 and 13 SD below the population age-related mean. There was no clinical correlation between sex and the degree of microcephaly. In most of the families with multiple affected individuals, except three families, differences in head circumferences did not vary by more than two SD (table 3). The ages of all patients were between 2 and 73 years, the mean age being 19. Intellectual quotient (IQ) scores measured in all patients revealed a degree of intellectual disability ranging from moderate to profound, with no correlation between sex and the degree of mental retardation. In addition, there was no meaningful difference between the IQ levels and MCPH loci/ genes.
Clinical findings
In 20 of the 112 microcephalic families, other symptoms were observed such as short stature, ataxia, autism, facial dysmorphism and skeletal deformities. Facial dysmorphism included hypertelorism, long philtrum, micrognathia, lip thickness, downslanting palpebral fissure, teeth widening and strabismus. Skeletal deformities demonstrated in patients included toe shortening, joint stiffness, club foot, waddling gait, pectus incarnatum, large toes and sandal foot (see table 4 ). These features were observed in some of the families linked to different MCPH loci, and we can not conclude that the additional changes are the result of MCPH in these families.
Genotyping and sequencing results
In total, 112 families were screened for MCPH loci, and 31 families (27.7%) using microsatellite analyses revealed homozygosity at one of the seven known MCPH loci. Among the 92 nonsyndromic families, 29 (31.5 %) showed homozygosity at any of the known MCPH loci. In agreement with previous findings,
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MCPH5 (ASPM) was the most prevalent locus with linkage in 13 families (14.1%). Eight families (8.7%) showed homozygosity at MCPH1, two (2.2%) at MCPH2, four (4.3%) at MCPH6, and two (2.2%) at MCPH7. Two out of 20 families with additional feature were linked to two loci, MCPH2 and MCPH6.
In total, 31 families with two or more affected individuals showed homozygosity at any of the MCPH loci, with all families having two or more affected individuals. Thus, the frequency of familial cases with linkage to either of the known MCPH loci was 31.6% (31 of 98 families).
Subsequent sequencing revealed eight novel mutations in MCPH1 (one of which was previously reported by Garshasbi et al 12 ), 10 novel mutations and one previously reported mutation in ASPM and one novel mutation in CENPJ. No mutations were found in the remaining families (11 of 31) with homozygosity at the MCPH loci. The results of mutation screening are summarised in table 3. All DNA changes and mutations not found in 160 German and 190 Iranian normal controls. Also, all mutations detected in affected individuals have been investigated in normal siblings and parents of these families.
We were unable to establish any linkage for the remaining 81 families (72.3%), of which 14 families had sporadic cases.
Karyotyping results
GTG banding, with the average resolution of 450e500 bands per haploid set, demonstrated a normal karyotype in all patients. However, in patients with MCPH1 mutations, chromosomes appeared curly with a high level of breakage, and there was increased number of prophase looking cells (figure 1), representing about 80% of the total number of cells compared with 13% in normal controls. Both features are consistent with premature chromosome condensation, a previously reported characteristic in patients with MCPH1 mutations. 24 
DISCUSSION
In this study, we investigated 112 Iranian families with nonsyndromic forms (92 of 112) of microcephaly and microcephaly associated with some additional features (20 of 112). Of the families with patients that had additional clinical features, one family showed linkage to MCPH2 and one to MCPH6 (CENPJ). In patients from the latter, we detected a novel mutation in the CENPJ gene. Interestingly, the patients showed seizures, a feature which was not observed in previous studies, where none of the reported patients with mutations in CENPJ had clinical features other than microcephaly. 21 22 25 In two families with apparent homozygosity at the MCPH5 locus, no mutations in ASPM were detected, which might indicate that either the mutation is located in regulatory sequences of the gene (which had not been screened in this study) or that there might exist another MCPH gene in this region. Tentative evidence for a second causative gene in the region has been shown previously by Wallerman et al 29 in five families and Gul et al 20 in nine families linked to the MCPH5 locus.
The novel ASPM missense change (c.5584A>C) in exon 18 of the ASPM gene we found in family M-064 converts the conserved basic amino acid lysine to a neutral glutamine (K1862Q) in the IQ repeat motif 25 of the protein (amino acid 1854e1880). This novel mutation is the first missense mutation in ASPM gene. Even though our results lack a functional study for this missense mutation in the ASPM gene, the size of the family, lack of the homozygous mutation in normal siblings and lack of this mutation in the ethnically matched control subjects as well as absence of any other changes even in the regulatory region of the gene suggest that this missense change might disrupts the function of the protein. Mutations in IQ repeat motif 25 may disrupt the interaction of ASPM with calmodulin and calmodulin-related proteins, 30 and this may also be true for 30 This is also the case in one of the mutations we found in intron5 (c.436+1G>T) of MCPH1.
In this gene, we also found four large deletions in families M-282 (del exon 4), M-8700071 (del exon 3), M-8700008 (del exon 2 and 3) and M-019 (del exon 1e6), which leads to truncation of microcephalin. Moreover, we found two missense mutations in two families M-8700173 (c.215C>T/S72L) and M-8700070 (c.147C>G/H49Q) that are located in the BRCT1 domain of the microcephalin protein. A frame shift mutation was found in family M-8600133 (c.566_567insA/N189fs). Microcephalin is predicted to contain three BRCA1 C-terminal (BRCT) domains. These domains interact to form homo/hetero BRCT multimers. 31 We just found one novel missense mutation in CENPJ in family M-238 (c.2462C>T/T821M) which may be a disrupted TCP10 complex in CENPJ protein. The N-terminus of 4.1R-135 interacts with the C-terminal Tcp10 domain of CENPJ, and CENPJ is associated with the g-tubulin ring complex. It has, therefore, been hypothesised that 4.1R-135 protein serves as an adaptor that anchors the CENPJ/g-tubulin complex to the centrosome. In vitro evidence shows that CENPJ can inhibit microtubule nucleation from the g-tubulin ring complex and is also able to depolymerise Taxol-stabilised microtubules. Therefore, this mutation can inhibit the normal function of CENPJ protein. 32 With respect to the clinical manifestation of ASPM mutations, it is noteworthy that families with nonsense mutations in this gene (M-136, M-273 and M-8500316) also presented with short stature. Up to now, this was only observed in patients with mutations in MCPH1. In addition to that, we observed the first case of ASPM mutations in microcephalic patients with congenital hearing loss. We therefore excluded one of the most frequent causes of congenital hearing loss, mutations in the GJB2 gene encoding connexin 26, by sequencing. These observations show that the spectrum of clinical manifestations in affected individuals with mutations in ASPM is wider than previously reported.
In order to compare our data with the other previously reported study, we removed our 14 singleton families from our data. The remaining families all of which had two or more affected individuals were families with consanguineous marriages and autosomal recessive pattern of inheritance. We could establish homozygosity at one of the known MCPH loci for less than onethird of our families, and for two of three of our families, the genetic causes remained to be solved. Particularly ASPM defects among the 98 familial cases were 13.3% (13 of 98) much less prevalent than in the Pakistani's population, where frequencies between 43% and 55% were reported, 20 23 or in India where Kumar et al 3 found a frequency of 33%. We also observed much lower frequencies of MCPH1, MCPH7, MCPH6 and MCPH2 mutations in the Iranian compared with the other populations (table 5) . Therefore, the Iranian population may provide a unique source for the identification of further genes with causative mutations in autosomal recessive primary microcephaly. 
